Top Clinical Trials companies in Australia by Net Cash Used For Investing Activities
Australia
# |
Name |
Net Cash Used For Investing Activities |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
|---|---|---|---|---|---|---|---|
| 1 |
USD 218.40 K
|
June 30, 2024 | USD 2.04 | -5.56% |
|
Australia |
|
| 2 |
USD -3.82 K
|
June 30, 2024 | USD 4.80 | 5.03% |
|
Australia |
|
| 3 |
USD -33.49 K
|
June 30, 2024 | NA |
|
Australia |
||
| 4 |
USD -97.00 K
|
June 30, 2024 | USD 1.90 | -4.74% |
|
Australia |
|
| 5 |
USD -277.00 K
|
June 30, 2024 | USD 1.67 | 2.45% |
|
Australia |
|
| 6 |
USD -993.47 K
|
June 30, 2024 | USD 1.23 | -0.40% |
|
Australia |
|
| 7 |
USD -1.12 M
|
June 30, 2024 | USD 0.74 | 1.48% |
|
Australia |
|
| 8 |
USD -2.66 M
|
Dec. 31, 2023 | USD 6.16 | 2.82% |
|
Australia |
|
| 9 |
USD -4.83 M
|
June 30, 2024 | USD 2.33 | 0.08% |
|
Australia |
|
| 10 |
USD -14.01 M
|
June 30, 2024 | USD 2.09 | 0.97% |
|
Australia |
|
| 11 |
USD -17.36 M
|
Dec. 31, 2023 | USD 18.33 | -0.84% |
|
Australia |
|
| 12 |
USD -19.36 M
|
June 30, 2024 | USD 7.27 | 0.71% |
|
Australia |
|
| 13 |
USD -25.87 M
|
June 30, 2024 | USD 0.74 | 0.62% |
|
Australia |
|
| 14 |
USD -36.88 M
|
June 30, 2024 | USD 2.46 | 10.79% |
|
Australia |
|
| 15 |
USD -1.26 B
|
June 30, 2024 | USD 169.95 | -0.56% |
|
Australia |
Frequently Asked Questions
-
Which Clinical Trials company in Australia has the highest Net Cash Used For Investing Activities ?
The Clinical Trials company in Australia with the highest Net Cash Used For Investing Activities is Immuron Limited (NasdaqCM: IMRN) at USD 218.40 K.
-
Which Clinical Trials company in Australia has the lowest Net Cash Used For Investing Activities ?
The Clinical Trials company in Australia with the lowest Net Cash Used For Investing Activities is CSL Limited (ASX: CSL.AX) at USD -1.26 B.
-
What are the top 10 Clinical Trials companies in Australia by Net Cash Used For Investing Activities ?
The top 10 Clinical Trials companies in Australia by Net Cash Used For Investing Activities are Immuron Limited, Alterity Therapeutics Limited, Opthea Limited, Mesoblast Limited, Incannex Healthcare Limited, PolyNovo Limited, Cogstate Limited, Anteris Technologies Ltd, Australian Clinical Labs Limited and Immutep Limited.
-
What are the bottom 10 Clinical Trials companies in Australia by Net Cash Used For Investing Activities ?
The bottom 10 Clinical Trials companies in Australia by Net Cash Used For Investing Activities are CSL Limited, Clarity Pharmaceuticals Ltd, Monash IVF Group Limited, Clinuvel Pharmaceuticals Limited, Telix Pharmaceuticals Limited, Immutep Limited, Australian Clinical Labs Limited, Anteris Technologies Ltd, Cogstate Limited and PolyNovo Limited.
